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Abstract
Background: Corynebacterium urealyticum is an opportunistic pathogen that normally lives on skin and mucous
membranes in humans. This high Gram-positive bacteria can cause acute or encrusted cystitis, encrusted pyelitis,
and pyelonephritis in immunocompromised patients. The bacteria is multi-drug resistant, and knowledge about the
genes that contribute to its virulence is very limited. Two complete genome sequences were used in this
comparative genomic study: C. urealyticum DSM 7109 and C. urealyticum DSM 7111.
Results: We used comparative genomics strategies to compare the two strains, DSM 7109 and DSM 7111, and to
analyze their metabolic pathways, genome plasticity, and to predict putative antigenic targets. The genomes of
these two strains together encode 2,115 non-redundant coding sequences, 1,823 of which are common to both
genomes. We identified 188 strain-specific genes in DSM 7109 and 104 strain-specific genes in DSM 7111. The high
number of strain-specific genes may be a result of horizontal gene transfer triggered by the large number of
transposons in the genomes of these two strains. Screening for virulence factors revealed the presence of the
spaDEF operon that encodes pili forming proteins. Therefore, spaDEF may play a pivotal role in facilitating the
adhesion of the pathogen to the host tissue. Application of the reverse vaccinology method revealed 19 putative
antigenic proteins that may be used in future studies as candidate drug or vaccine targets.
Conclusions: The genome features and the presence of virulence factors in genomic islands in the two strains of
C. urealyticum provide insights in the lifestyle of this opportunistic pathogen and may be useful in developing
future therapeutic strategies.
Background
The species Corynebacterium urealyticum was proposed
in 1986, but this bacteria was first isolated between June
1983 and March 1984, when four patients were diag-
nosed with alkaline-encrusted cystitis. The published
case report describes the isolates as belonging to the
Corynebacterium group D2 [1,2]. Chemotaxonomic
studies and 16S rRNA sequence comparisons showed
that C. urealyticum was more closely related to Coryne-
bacterium lipophilic species such as Corynebacterium
jeikeium, but could be differentiated from C. jeikeium
based on its ability to hydrolyze urea [3]. C. urealyticum
is a Gram-positive, non-spore-forming, aerobic, and
slow-growing bacteria. Its cell wall is composed of pepti-
doglycan, menaquinone, mycolic acids, and cellular fatty
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acids, which is the common composition of the cell
walls of Corynebacterium species [4].
C. urealyticum is an opportunistic pathogen commonly
isolated from the skin and mucous membranes of hospi-
talized patients. The pathogen mainly causes acute or
encrusted cystitis, encrusted pyelitis, and pyelonephritis
[4]. Its urease activity is the main factor that contributes
to the ability of C. urealyticum to colonize the urinary
tract where its presence is associated with alkaline pH
and the formation of ammonium magnesium phosphate
stones [1,2]. C. urealyticum is a multi-drug resistant bac-
terium and its treatment requires the administration of
multiple drugs and additional invasive interventions [4,5].
Currently, the complete genome sequences of only two
C. urealyticum strains, DSM 7109 and DSM 7111, are
publicly available. In these two genomes, the antibiotic
resistance genes were located in mobile DNA, suggesting
that the multidrug resistance was acquired through hori-
zontal gene transfer [6,7].
In this work, we compared the genome sequences of
the two C. urealyticum multidrug resistance strains
DSM 7109 and DSM 7111, focusing on differences in
the gene content and metabolic pathways between the
two strains. We also attempted to identify new candi-
date targets that can be used in the development of
drugs or vaccines against this pathogen.
Methods
Genome sequences of C. urealyticum strains DSM 7109
and DSM 7111
C. urealyticum DSM 7109 was isolated from a patient
with alkaline-encrusted cystitis and C. urealyticum DSM
7111 was isolated from the urine samples of a 9-year-old
patient with an ectopic kidney. The genome sequences of
both these strains were retrieved from the NCBI Gen-
Bank database (http://www.ncbi.nlm.nih.gov/genbank/)
[8] [GenBank:NC_010545.1, GenBank: NC_020230.1].
Bioinformatics analysis
The origin of chromosomal DNA replication (oriC) gene
was predicted using the Ori-Finder web program [9].
The Ori-Finder prediction was based on a combined
process: (i) gene identification involving analysis of base
composition through Z-curve method; and, (ii) occur-
rence of genes frequently close to oriCs (distribution of
dnaA boxes along the genome) [9]. The CRISPRs were
predicted using the CRISPRfinder web program [10].
These regions are important because they confer protec-
tion against bacteriophages. The comparative analysis
was done using the EDGAR web-program that compares
genome content based on the calculation of the BLAST
score ratio by automatically adjusted cutoff for each
selected dataset [11].
In silico identification metabolic pathway construction
The metabolic pathways reconstruction of C. urealyti-
cum was performed using the genome sequence file in
FASTA format and the genome annotation file in GBK
format. Metabolic pathways databases for strains DSM
7109 and DSM 7111 were created using the Pathway
Tools 13 software (available at http://bioinformatics.ai.
sri.com/ptools/), developed by SRI International [12].
The Pathway Tools software contains algorithms that
can predict the metabolic pathways of an organism from
its genome by comparing it to a reference pathways
database known as the MetaCyc Database [13]. Con-
struction of a metabolic pathways database was done
using the BioCyc collection [14].
Prediction of genome plasticity of C. urealyticum DSM
7109 and DSM 7111 strains
Prediction of genomic islands in C. urealyticum gen-
omes was done using PIPS software [15]. PIPS detects
genome signatures like C+G content, codon usage
deviation, high concentrations of virulence factors,
hypothetical proteins, the presence of transposases and
tRNA flanking sequences, and absence of query regions
in non-pathogenic organisms. C. glutamicum ATCC
13032 was used as the closely related non-pathogenic
species to C. urealyticum in PIPS. The BRIG software
[16] was used for plasticity comparisons among C. urea-
lyticum (DSM 7109 and DSM 7111 strains), C. pseudo-
tuberculosis 1002, C. diphtheriae NCTC 13129,
C. ulcerans 809, and C. glutamicum ATCC 13032.
Prediction of putative antigenic targets of C. urealyticum
To identify antigenic targets, we used the strategy
described by Barh et al. [17] with modifications. We also
adopted the four rules as per the reverse vaccinology
strategy of Rappuoli et al. [18] for final selection of the
putative vaccine targets. Rule I: consider the antigenic
proteins that are either secreted proteins, surface-
exposed proteins, or membrane proteins so that they can
be exposed to the host, and therefore can be promptly
recognized by the host immune system [18]; Rule II:
major histocompatibility complex (MHC) I and II bind-
ing properties with adhesion probability greater than 0.51
and absence of similarity to host proteins [19]; Rule III:
protein conservation among different genomes [19]; and
Rule IV: virulence factors are normally encoded within
genomic islands [18]. Rule IV does not exclude the tar-
gets from Rule III.
SurfG+ software [20] was used to predict targets
according to the Rule I. This software classifies proteins
according to their subcellular location using the pre-
sence or absence of signal peptides, retention signals,
and transmembrane helices. To apply Rule II, the
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proteins predicted by surfG+ were analyzed using the
Vaxign software [19]. Because the aim of this work was
to identify vaccine candidates, the predicted proteomes
were screened for proteins that were potentially anti-
genic in both strains (Rule III). To achieve this, we used
the Artemis Comparison Tool [21] with BLAST align-
ment comparison files and searched for antigenic pro-
teins that show more than 70% similarity in 70% of their
extensions in both strains. Base on Rule IV, we screened
the detected antigenic proteins for antigenic targets har-
bored by shared genomic islands in the two strains.
Results and discussion
Genomic architecture and features of C. urealyticum
strains DSM 7109 and DSM7111
Strains DSM 7109 and DSM 7111 were isolated from
patients with alkaline-encrusted cystitis [6,7]. The geno-
mic composition of these two strains is very similar; i.e.,
both sequences have the same G+C content, coding
density, ribosomal RNAs clusters, and clustered regu-
larly interspaced short palindromic repeats (CRISPRs).
However, the sizes of the two genomes are different: the
DSM 7111 genome contains 2,316,065 bp and is 50 Kb
smaller than the DSM 7109 genome with 2,369,219 bp.
As expected, the number of coding sequences in the
DSM 7111 genome (1,927 protein coding regions) is
lower than in the DSM 7109 genome (2,011 protein
coding regions) because both genomes have the same
coding density. These data indicate a strain-specific dif-
ference in the gene repertories in both these isolates.
Relevant data and general features from both genome
sequences are summarized in Table 1.
Our analysis of the GC skew [(G-C)/(G+C)] revealed
that both genome sequences contained a bi-directional
replication mechanism (Figure 1). The origin of the
chromosomal replication (oriC) gene is located between
the replication initiator genes dnaA (downstream) and
dnaN (upstream) and has a size of 843 bp. However, the
G/C skew analysis did not confirm that the replication
termination site, dif, was located at the 180° position
from oriC [9,22].
CRISPRs are often associated with cas genes that nor-
mally provide resistance against bacteriophages [23].
One CRISPR region was predicted in each genome
(strains DSM 7109 and DSM 7111) using the CRISPR-
Finder software [10]. Both these regions were flanked by
seven cas genes. The size of one CRISPR was 28 bp and
the consensus sequence was the same for the CRISPRs
in both genomes. Each CRISPR was separated by 69 bp
(Table 2).
Gene sharing among the two C. urealyticum strains
Orthologous genes were detected using the EDGAR
software, which defines subsets of genes using the SRV
method to predict orthologous genes in prokaryotic gen-
omes [11]. We found that the DSM 7109 and DSM
7111 genomes together encode 2,115 no-redundant cod-
ing gene sequences; 1,823 (86.2%) of these coding gene
sequences were common to both strains, and 188 and
104 were specific to DSM 7109 and DSM 7111, respec-
tively. Species-specific genes have been linked to niche
adaptation of microorganisms. A previous study of 17
Escherichia coli strains found that less than 50% of the
genes (2,200 genes in a total of 5,000 genes) were shared
among these strains [24]. Therefore, we can infer that
the DSM 7109 and DSM 7111 genomes are very similar
because they share a high proportion of their genes.
A previous study of four Corynebacterium pseudotuber-
culosis strains [25] also reported a large number in
shared genes; 1,851 (77.9%) genes in a total of 2,377
genes. Clearly, the numbers of core genes are likely to
reduce when more strains of C. urealyticum are added,
as was shown previously by Soares and colleagues in a
study of 15 C. pseudotuberculosis strains were 1,504
(54.5%) genes in a total of 2,782 genes were shared [26].
Plasticity of the C. urealyticum DSM 7109 and DSM 7111
genomes
Genome plasticity has been used to provide insights into
genome evolution through the study of horizontally
acquired genomic regions. The transfer of blocks of
genes (genomic islands) normally correlates with the
acquirement of a given function, like virulence (patho-
genicity islands), degradation of secondary compounds
(metabolic islands), antibiotic resistance (resistance
islands) and symbiotic relationships with Leguminosae
(symbiotic islands)[15]. Furthermore, because genomic
islands are acquired from a different organism, they are
responsible for deviations in genomic signatures such as
codon usage and G+C content once they reflect the
genomic signature of the donor organism [27]. We used
the PIPS software [15] to predict genomic islands in
both C. urealyticum strains. Twenty-six genomic islands
were predicted in each genome (Figure 1). DSM 7109
had 556 genes present in the genomic islands and DSM
7111 had 496 genes. We identified 403 genes in the
genomic islands that belonged to the shared genes
Table 1. General features of the genomes of
C. urealyticum strains DSM 7109 and DSM 7111
Feature DSM 7109 DSM 7111
Genome size (bp) 2,369,219 2,316,065
C+G content (%) 64.2 64.2
Coding sequences 2,084 2,007
Coding density (%) 90.16 89.53
ribosomal RNAs 3 × (16S - 23S - 5S) 3 × (16S - 23S - 5S)
transfer RNAs 51 54
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dataset, meaning that the majority of genes that were
acquired by horizontal gene transfer were commonly
shared genes.
Previous studies on genomic islands in C. pseudotuber-
culosis and C. diphtheriae identified 16 and 52 genomic
islands, respectively [26,28]. Only nine of the genes in the
genomic islands were shared among C. urealyticum strains
DSM 7109 and DSM 7111, C. pseudotuberculosis 1002,
and C. diphtheriae NCTC 13129 (Table 3). The low num-
ber of shared genes among different species in the same
genus is expected because their habitats are different and
genomic islands are normally acquired through horizontal
gene transfer as was shown previously by Perrin and col-
leagues [29]. Pathogenicity islands contain genes corre-
lated with virulence [27]. Therefore, these genes may be
good candidates for the development of vaccines or drugs
[15]. When we compared the orthologs of the candidate
virulence factors reported in C. ulcerans [30] with the
genes in the pathogenicity islands in C. urealyticum we
found only one common gene and this gene was anno-
tated with unknown function (ID: CU7111_1212 for DSM
7111; ID: cur_1230 for DSM 7109).
Figure 1 Comparative genomic maps of C. urealyticum strains DSM 7109 and DSM 7111. The C. urealyticum DSM 7109 map (left) used as
the reference. The C. urealyticum DSM 7111 map (right) used as the reference. From the inner to outer circles on the genome maps: C.
urealyticum DSM 7109 (Cur_7109) then C. urealyticum DSM 7111 (Cur_7111) for the map on the left; C. urealyticum DSM 7111 (Cur_7111) then C.
urealyticum DSM 7109 (Cur_7109) for the map on the right; followed by C. pseudotuberculosis 1002 (Cp_1002), C. diphtheriae NCTC 13129
(Cd_NCTC13129), C. ulcerans 809 (Cul_809), C. glutamicum ATCC 13032 (Cg_ATCC13032). The outermost circles in both maps indicate the 26
genomic islands (PiCur 1-26).
Table 2. Structural features of CRISPR loci predicted in C. urealyticum strains DSM 7109 and DSM 7111






























69 28 bp GGCTCATCCCCGCTGGCGCGGGGAGCAC
*CRISPR, clustered regularly interspaced short palindromic repeats
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Prediction of candidate vaccine targets for C. urealyticum
The sub-cellular location of proteins in DSM 7109 and
DSM 7111 was predicted using the SurfG+ software
[31], which classifies genes into four categories: cyto-
plasmic, membrane, PSE (putative surface-exposed), and
secreted (Table 4). We used the four rules described in
the reverse vaccinology strategy (see the Methods sec-
tion for details) for final selection of putative vaccine
targets. According to Rule I, proteins exposed to the
host are better candidates because they can be promptly
recognized by the immune system; for example, secreted
proteins, surface-exposed proteins, and membrane pro-
teins. We predicted 590 and 579 putative candidates for
DSM 7109 and DSM 7111, respectively, using Rule I.
The encoded proteins were submitted to the Vaxign
software [19], which detected 54 and 57 proteins with
antigenic properties in DSM 7109 and DSM 7111,
respectively. Using Rule III, we considered only proteins
that were shared by both strains, which resulted in 46
candidates for both strains. Finally, using Rule IV, we
identified 19 proteins that were shared by both strains
and that were encoded within genomic islands as vac-
cine candidates (Table 5). Among these 19 vaccine can-
didates, six were annotated with a function and a gene
name. These proteins have been identified as potential
vaccine targets in previous studies [30,32-36], but as yet
no tests have been carried out to confirm this.
The rpfC gene (resuscitation-promoting factor) is a
member of a protein family (rpfA, rpfB, rpfD, and rpfE)
found in Actinobacteria. The protein encoded by rpfC
plays a role in stimulating resuscitation of dormant cells
and in the multiplication of normal viable bacteria. Studies
in Mycobacterium luteus with a disrupted rpf gene were
not possible because of the absence of a second functional
copy of the gene, suggesting that this protein is essential
for normal growth and reduces the lag phase of diluted
fast-growers [32,37].
The mepA gene (penicillin-insensitive murein endo-
peptidase) in E. coli encodes a protein the cleaves the
D-alanyl-meso-2,6-diamino-pimelyl amide bond of
peptidoglycans [38]; however, this protein is sensitive to
metal-chelating agents such as lipoteichoic acid and
deoxyribonucleic acid [39]. Previous studies with
metallopeptidases showed that animals infected with
C. pseudotuberculosis reacted to the mepA protein,
while non-infected animals did not. This protein has
transmembrane domains, another strong indication
that it may make a good molecular vaccine target
[33,40].
The lpps (lipoprotein) gene encodes a protein that is
associated with cell envelopes and has four known lipo-
protein functions: (i) structural function (murein lipo-
proteins); (ii) transport function (substrate-binding
proteins of ABC transporters in Gram-positive bacteria);
(iii) adhesion function; and (iv) enzymatic function. The
lipoprotein present in C. urealyticum has an L,D-trans-
peptidase catalytic domain, which gives the bacteria the
ability to resist beta-lactam antibiotics by inhibiting
PBPs (penicillin-binding protein) [34,41].
The cmtA (trehalose corynomycol transferase) gene
encodes a protein that has catalytic function. It plays a
role in the transfer of mycolic acids through trehalose
monocorynomycolate on the cell wall arabinogalactan to













cur_1756 CU7111_1693 Cp1002_1932 DIP2331 - Putative aldehyde dehydrogenase
cur_1817 CU7111_1751 Cp1002_1909 DIP2133 - Fe-S oxidoreductase
cur_1897 CU7111_1828 Cp1002_1870 DIP0236 srtB Fimbrial associated sortase (Surface protein
transpeptidase)
cur_1898 CU7111_1829 Cp1002_1872 DIP0235 spaD Putative surface-anchored protein (Fimbrial
subunit)
cur_1899 CU7111_1830 Cp1002_1874 DIP0233 srtC Fimbrial associated sortase (Surface protein
transpeptidase)
cur_1933 CU7111_1856 Cp1002_0132 DIP0247 tadA tRNA-specific adenosine deaminase
cur_1934 CU7111_1857 Cp1002_0131 DIP0246 - Hypothtical protein
cur_1935 CU7111_1858 Cp1002_0130 DIP0245 tyrA Prephenate dehydrogenase
cur_1939 CU7111_1861 Cp1002_0120 DIP0179 - Putative dicarboxylate uptake system
The genomes of C. urealyticum strains DSM 7109 and DSM 7111, C. pseudotuberculosis 1002, and C. diphtheriae NCTC 13129 were compared.
Table 4. Subcellular location of proteins from
C. urealyticum strains DSM 7109 and DSM 7111
Feature DSM 7109 DSM 7111
Cytoplasmic proteins 1431 1356
Membrane proteins 311 302
PSEa proteins 200 198
Secreted proteins 79 79
aPutative surface-exposed
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another trehalose monocorynomycolate to produce tre-
halose dicorynomycolate [42].
The spaD and spaE genes are part of the spaDEF cluster
that encodes adhesive pilus structures that are surface-
anchored to the cell walls of Corynebacterium where they
probably facilitate the adhesion of the pathogen to the
host tissue. We detected the spaF gene in the DSM 7109
and DSM 7111 genomes, as well as the sortase encoding
genes srtB and srtC. The genome organization of the
spaDEF cluster in the two C. urealyticum strains is similar
to cluster organization in C. diphitheriae NCTC 13129
and C. ulcerans 809 and BR-AD22 strains [30,43]. How-
ever, the spaABC cluster of genes proposed as an essential
virulence factor in C. diphtheria [35] was absent in both
strains of C. urealyticum analyzed.
The crcB gene encodes a putative membrane protein,
important for the reducing the fluoride concentration in
cells, thus reducing its toxicity. Fluoride ions reduce cell
growth, even when present in millimolar concentrations.
Thus, we can infer that crcB gene is an efficient resis-
tance mechanism [36].
Differences in metabolic pathways in the C. urealyticum
genomes
To predict the metabolic pathways encoded in the DSM
7109 and DSM 7111 genomes, we used the Pathway
Tools software (version 13.0) [44], and detected 226 and
271 pathways in DSM 7109 and DSM 7111, respectively.
We also identified 942 and 1,116 metabolic reactions for
these strains (Table 6).
Comparative analysis of two pathway classes (Bio-
synthesis and Degradation/Utilization/Assimilation)
showed that the DSM 7109 and DSM 7111 genomes
had 139 and 174 Biosynthesis pathways, respectively
(Table 7), which is quite different from the number of
pathways we found previously in other species in the
same genus; for example, C. pseudotuberculosis strains
1002 and C231 in which 105 and 104 Biosynthesis path-
ways were predicted, respectively [25]. The number of
Degradation/Utilization/Assimilation pathways predicted
in the DSM 7109 and DSM 7111 genomes where simi-
lar, 70 pathways in DSM 7109 and 66 pathways in DSM
7111 (Table 7).
On further analysis, we found that the DSM 7109 and
DSM 7111 genomes had 25 and 57 unique metabolic
pathways (Table S1, additional file 1), respectively, even
though both the strains were isolated from humans and
caused the same symptoms [6,7].
Table 5. Putative antigenic proteins identified using Vaxign and shared by two C. urealyticum strains
DSM 7109 - Locus_Tag DSM 7111 - Locus_Tag Gene name Subcellular location Gene product
cur_0025 CU7111_0027 rpfc secreted Resuscitation-promoting factor RpfC
cur_0151 CU7111_0157 - secreted Putative secreted protein
cur_0291 CU7111_0284 - PSE Putative surface-anchored protein
cur_0295 CU7111_0288 - PSE Hypothetical protein
cur_0527 CU7111_0510 - PSE Putative secreted protein
cur_0530 CU7111_0513 mepA secreted Putative secreted metallopeptidase
cur_1309 CU7111_1290 - PSE Hypothetical protein
cur_1319 CU7111_1300 - PSE Putative ribonuclease
cur_1350 CU7111_1330 - secreted Putative secreted protein
cur_1399 CU7111_1390 lppS PSE Putative lipoprotein
cur_1604 CU7111_1545 - secreted Hypothetical protein
cur_1636 CU7111_1577 - secreted Putative secreted protein
cur_1834 CU7111_1766 - PSE Hypothetical protein
cur_1842 CU7111_1775 cmtA secreted Trehalose corynomycolyl transferase A
cur_1896 CU7111_1827 spaE PSE Putative surface-anchored protein (fimbrial subunit)
cur_1898 CU7111_1829 spaD PSE Putative surface-anchored protein (fimbrial subunit)
cur_1958 CU7111_1880 - secreted Hypothetical protein
cur_1959 CU7111_1881 - secreted Hypothetical protein
cur_1980 CU7111_1900 crcB membrane Putative fluoride ion transporter CrcB
Table 6. Numbers of gene data types in C. urealyticum
strains DSM 7109 and DSM 7111
Data type DSM 7109 DSM 7111
Genes 2082 1998
Pathways 226 271
Metabolic reactions 942 1116
Transport reactions 34 36
Polypeptides 2022 1935
Enzymes 536 543
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Conclusions
To our knowledge, this is the first comparative genomic
study using the complete genome sequences of two
C. urealyticum strains, DSM 7109 and DSM 7111. Our
analyses provided insights into the genome architecture
and the gene content of this species. We found that the
C. urealyticum DSM 7111 genome was 50 kb shorter
than the C. urealyticum DSM 7109 genome. This differ-
ence in genome size may be linked to the large number
of genomic islands (26 for each genome) predicted for
both genomes. The genomic islands may have resulted
from the horizontal transfer of genes, leading to the
acquisition of many strain-specific genes. We detected a
high number of strain-specific genes in the two genomes
compared with the low number of species-specific genes
that have been reported in previous studies of others spe-
cies of Corynebacterium [25,30]. The horizontal transfer
of genes may also explain why C. urealyticum is multi-
drug resistant; i.e., it has received virulence genes by hori-
zontal transfer [4,5].
C. urealyticum is a pathogenic opportunistic bac-
teria although it showed the spaDEF operon (viru-
lence factor), with a structure similar to that of
pathogenic species like C. diphtheriae and C. ulcerans.
This operon encodes an adhesive pilus responsible for
facilitating the adhesion of the pathogen to host cells
[28,43].
This comparative genomic study of two C. urealyti-
cum strains provides a basis using reverse vaccinology
to predict new antigenic targets. However, additional
C. urealyticum strains will have to be studied to create
effective vaccines against this bacterium.
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Table 7. Numbers of pathways in C. urealyticum strains DSM 7109 and DSM 7111
Pathway class DSM 7109 DSM 7111
Biosynthesis 139 174
-Amines and Polyamines Biosynthesis 4 5
-Amino Acids Biosynthesis 27 32
-Aminoacyl-tRNA Charging 3 3
-Aromatic Compounds Biosynthesis 2 4
-Carbohydrates Biosynthesis 6 9
-Cell Structures Biosynthesis 4 5
-Cofactors, Prosthetic Groups, Electron Carriers Biosynthesis 34 40
-Fatty Acids and Lipids Biosynthesis 6 8
-Metabolic Regulators Biosynthesis 1 1
-Nucleosides and Nucleotides Biosynthesis 18 25
-Other Biosynthesis 5 5
-Secondary Metabolites Biosynthesis 4 3
Degradation/Utilization/Assimilation 70 66
-Alcohols Degradation 1 4
-Amines and Polyamines Degradation 5 3
-Amino Acids Degradation 18 17
-Aromatic Compounds Degradation 3 2
-C1 Compounds Utilization and Assimilation 1 3
-Carbohydrates Degradation 4 2
-Carboxylates Degradation 5 6
-Degradation/Utilization/Assimilation - Other 2 1
-Fatty Acid and Lipids Degradation 3 4
-Inorganic Nutrients Metabolism 10 8
-Nucleosides and Nucleotides Degradation 6 5
-Protein Degradation 2 2
-Secondary Metabolites Degradation 2 2
-Steroids Degradation 2 2
Generation of Precursor Metabolites and Energy 16 25
Total 185 216
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